Literature DB >> 33523598

Critical amino acids in the TM2 of EAAT2 are essential for membrane-bound localization, substrate binding, transporter function and anion currents.

Dongmei Mai1,2,3, Rongqing Chen4, Ji Wang1,2,3, Jiawei Zheng4, Xiuping Zhang5, Shaogang Qu1,2,3.   

Abstract

Excitatory amino acid transporter 2 (EAAT2), the gene of which is known as solute carrier family 1 member 2 (SLC1A2), is an important membrane-bound transporter that mediates approximately 90% of the transport and clearance of l-glutamate at synapses in the central nervous system (CNS). Transmembrane domain 2 (TM2) of EAAT2 is close to hairpin loop 2 (HP2) and far away from HP1 in the inward-facing conformation. In the present study, 14 crucial amino acid residues of TM2 were identified via alanine-scanning mutations. Further analysis in EAAT2-transfected HeLa cells in vitro showed that alanine substitutions of these residues resulted in a decrease in the efficiency of trafficking/targeting to the plasma membrane and/or reduced functionality of membrane-bound, which resulted in impaired transporter activity. After additional mutations, the transporter activities of some alanine-substitution mutants recovered. Specifically, the P95A mutant decreased EAAT2-associated anion currents. The Michaelis constant (Km ) values of the mutant proteins L85A, L92A and L101A were increased significantly, whereas R87 and P95A were decreased significantly, indicating that the mutations L85A, L92A and L101A reduced the affinity of the transporter and the substrate, whereas R87A and P95A enhanced this affinity. The maximum velocity (Vmax) values of all 14 alanine mutant proteins were decreased significantly, indicating that all these mutations reduced the substrate transport rate. These results suggest that critical residues in TM2 affect not only the protein expression and membrane-bound localization of EAAT2, but also its interactions with substrates. Additionally, our findings elucidate that the P95A mutant decreased EAAT2-related anion currents. Our results indicate that the TM2 of EAAT2 plays a vital role in the transport process. The key residues in TM2 affect protein expression in the membrane, substrate transport and the anion currents of EAAT2.
© 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  alanine-scanning mutation; excitatory amino acid transporter 2; glutamate; transmembrane domain 2; transporter activity

Year:  2021        PMID: 33523598      PMCID: PMC7933967          DOI: 10.1111/jcmm.16212

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  55 in total

1.  De Novo Mutations in YWHAG Cause Early-Onset Epilepsy.

Authors:  Ilaria Guella; Marna B McKenzie; Daniel M Evans; Sarah E Buerki; Eric B Toyota; Margot I Van Allen; Mohnish Suri; Frances Elmslie; Marleen E H Simon; Koen L I van Gassen; Delphine Héron; Boris Keren; Caroline Nava; Mary B Connolly; Michelle Demos; Matthew J Farrer
Journal:  Am J Hum Genet       Date:  2017-08-03       Impact factor: 11.025

2.  Investigating the mechanism of substrate uptake and release in the glutamate transporter homologue Glt(Ph) through metadynamics simulations.

Authors:  Giovanni Grazioso; Vittorio Limongelli; Davide Branduardi; Ettore Novellino; Carlo De Micheli; Andrea Cavalli; Michele Parrinello
Journal:  J Am Chem Soc       Date:  2011-12-08       Impact factor: 15.419

3.  Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures.

Authors:  J C Jen; J Wan; T P Palos; B D Howard; R W Baloh
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

4.  Rigidity of the subunit interfaces of the trimeric glutamate transporter GltT during translocation.

Authors:  Maarten Groeneveld; Dirk-Jan Slotboom
Journal:  J Mol Biol       Date:  2007-06-29       Impact factor: 5.469

5.  Mechanisms of anion conduction by coupled glutamate transporters.

Authors:  Jan-Philipp Machtens; Daniel Kortzak; Christine Lansche; Ariane Leinenweber; Petra Kilian; Birgit Begemann; Ulrich Zachariae; David Ewers; Bert L de Groot; Rodolfo Briones; Christoph Fahlke
Journal:  Cell       Date:  2015-01-29       Impact factor: 41.582

Review 6.  EAAT2 and the Molecular Signature of Amyotrophic Lateral Sclerosis.

Authors:  Lauren Taylor Rosenblum; Davide Trotti
Journal:  Adv Neurobiol       Date:  2017

7.  Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice.

Authors:  Hong Guo; Liching Lai; Matthew E R Butchbach; Michael P Stockinger; Xiu Shan; Georgia A Bishop; Chien-liang Glenn Lin
Journal:  Hum Mol Genet       Date:  2003-08-05       Impact factor: 6.150

8.  Primary structure and functional characterization of a high-affinity glutamate transporter.

Authors:  Y Kanai; M A Hediger
Journal:  Nature       Date:  1992-12-03       Impact factor: 49.962

9.  Inhibitor design by wrapping packing defects in HIV-1 proteins.

Authors:  Ariel Fernández; Kristina Rogale; Ridgway Scott; Harold A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

10.  Structural intermediates in a model of the substrate translocation path of the bacterial glutamate transporter homologue GltPh.

Authors:  Sebastian Stolzenberg; George Khelashvili; Harel Weinstein
Journal:  J Phys Chem B       Date:  2012-05-02       Impact factor: 2.991

View more
  1 in total

1.  Critical amino acids in the TM2 of EAAT2 are essential for membrane-bound localization, substrate binding, transporter function and anion currents.

Authors:  Dongmei Mai; Rongqing Chen; Ji Wang; Jiawei Zheng; Xiuping Zhang; Shaogang Qu
Journal:  J Cell Mol Med       Date:  2021-02-01       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.